Barcode

company

About

Barcode designs a proprietary technology for use for personalized cancer drug screening.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$4M
Industries
Assisted Living,Biopharma,Biotechnology,Health Care,Nanotechnology
Founded date
Jul 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

Barcode designs a proprietary technology designed for use for personalized cancer drug screening. Its proprietary technology quickly and reliably assesses the efficacy of different cancer drugs directly on the tumor within the patient's own body, enabling physicians to access a new tool that matches each patient with the optimally potent medicine, during the different stages of the disease to improve cancer care.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$4M
Barcode has raised a total of $4M in funding over 2 rounds. Their latest funding was raised on Mar 9, 2019 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 9, 2019 Series A $4M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Barcode is funded by 1 investors. OurCrowd are the most recent investors.
Investor Name Lead Investor Funding Round
OurCrowd Series A